Earnings History Data for Vor Biopharma (VOR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Vor Biopharma

Vor Biopharma Inc. is a cell therapy company pioneering engineered hematopoietic stem cell therapies combined with targeted therapies for the treatment of cancer. Vor Biopharma Inc. is based in CAMBRIDGE, Mass.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	PM		VOR	Vor Biopharma	53.00	-0.40	-0.40	0.00	Vor Biopharma GAAP EPS of -$0.40 [11/8/2024 6:21 AM]	0.9396	0.11 (12.65%)	0.84	0.01 (0.72%)	0.63 - 3.14	743,787	740,000	17,953
Vor Biopharma GAAP EPS of -$0.40 [11/8/2024 6:21 AM] Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update [Nov-07-24 04:05PM]
08-08-2024	PM		VOR	Vor Biopharma Inc.	59.39	-0.41	-0.41	-0.45	Vor Biopharma GAAP EPS of -$0.41 [8/9/2024 6:33 AM]	0.8242	-0.01 (-0.82%)	0.82	-0.01 (-1.30%)	0.70 - 3.14	122,604	190,000	955
Vor Biopharma GAAP EPS of -$0.41 [8/9/2024 6:33 AM]
09-05-2024	PM		VOR	Vor Biopharma Inc.	119.98	-0.45	-0.37	-0.43	Vor Biopharma GAAP EPS of $0.45 [5/10/2024 7:20 AM]	1.70	-0.11 (-6.08%)	1.78	-0.03 (-1.66%)	1.62 - 5.70	217,788	270,000	1,725
Vor Biopharma GAAP EPS of $0.45 [5/10/2024 7:20 AM]
20-03-2024	AH		VOR	Vor Biopharma	130.00	-0.39	-0.49	0.00	Vor Biopharma GAAP EPS of -$0.39 beats by $0.11 [3/20/2024 5:02 PM]	1.96	0.16 (8.89%)	1.88	0.08 (4.44%)	1.62 - 6.18	566,459	320,000	12,612
Vor Biopharma GAAP EPS of -$0.39 beats by $0.11 [3/20/2024 5:02 PM]
07-11-2023	AH		VOR	Vor Biopharma	127.00	-0.49	-0.46	0.00	Vor Biopharma GAAP EPS of -$0.49 misses by $0.02 [11/7/2023 6:03 PM]	1.87	-0.12 (-6.03%)	1.92	-0.07 (-3.52%)	1.62 - 7.57	111,652	120,000	1,247
Vor Biopharma GAAP EPS of -$0.49 misses by $0.02 [11/7/2023 6:03 PM]
10-08-2023	PM		VOR	Vor Biopharma Inc.	176.10	-0.45	-0.42	-0.58	Vor Biopharma GAAP EPS of -$0.45 beats by $0.03 [8/11/2023 9:56 AM]	2.92	0.35 (13.62%)	2.66	0.09 (3.50%)	2.50 - 7.57	95,164	70,000	4,849
Vor Biopharma GAAP EPS of -$0.45 beats by $0.03 [8/11/2023 9:56 AM]
23-03-2023	AH		VOR	Vor Biopharma	215.00	-0.53	-0.56	0.00	Vor Biopharma Non-GAAP EPS of -$0.53 beats by $0.04 [3/23/2023 4:42 PM]	5.78	0.68 (13.33%)	0.0	0.0 (0.00%)	3.48 - 7.67	178,703	230,000	0
Vor Biopharma Non-GAAP EPS of -$0.53 beats by $0.04 [3/23/2023 4:42 PM] Vor Biopharma jumps 15% after Q4 update [3/24/2023 2:10 PM]
11-08-2022	AH	4:15 PM ET (Aug 11)	VOR	Vor Biopharma	180.00	-0.58	-0.67	0.00	Vor Biopharma GAAP EPS of -$0.58 beats by $0.08 [8/11/2022 5:33 PM]	5.40	0.42 (8.43%)	4.98	0.0 (0.00%)	3.83 - 18.52	89,657	70,000	717
Vor Biopharma GAAP EPS of -$0.58 beats by $0.08 [8/11/2022 5:33 PM] Vor Bio Reports Second Quarter 2022 Financial Results and Provides Company Update [Aug-11-22 04:15PM]
14-03-2022	AH	4:10 PM ET (Mar 14)	VOR	Vor Biopharma	318.00	-0.49	-0.55	0.00	Vor Biopharma GAAP EPS of -$0.49 beats by $0.08 [3/14/2022 5:47 PM]	7.70	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	58,477	0	0
Vor Biopharma GAAP EPS of -$0.49 beats by $0.08 [3/14/2022 5:47 PM] Vor Biopharma files for $350M mixed shelf offering [3/14/2022 5:56 PM] Vor Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update [Mar-14-22 04:30PM]
10-11-2021	AH		VOR	Vor Biopharma	635.00	-0.50	-0.58	0.00	Vor Biopharma EPS beats by $0.12 [11/10/2021 5:05 PM]	16.86	0.83 (5.18%)	16.03	0.0 (0.00%)	11.78 - 63.62	56,068	50,000	1,109
Vor Biopharma EPS beats by $0.12 [11/10/2021 5:05 PM] Vor Reports Third Quarter 2021 Financial Results and Provides Company Update [Nov-10-21 04:10PM] Vor to Present New Data on its Cell and Genome Engineering Platform at SITC Annual Meeting [Nov-09-21 08:30AM] We're Hopeful That Vor Biopharma (NASDAQ:VOR) Will Use Its Cash Wisely [Nov-11-21 12:51PM]
09-08-2021	AH		VOR	Vor Biopharma Inc.	496.00	-0.50	-0.47	0.00		13.01	-0.94 (-6.74%)	0.0	0.0 (0.00%)	12.01 - 63.62	131,129	100,000	0
Vor Reports Second Quarter 2021 Financial Results and Provides Company Update [Aug-09-21 04:05PM]
06-05-2021	AH		VOR	Vor Biopharma Inc.	943.00	-0.67	-0.83	0.00	Vor Biopharma EPS misses by $0.03 [5/6/2021 5:25 PM]	24.53	0.89 (3.76%)	0.0	0.0 (0.00%)	23.01 - 63.62	124,608	80,000	0
Vor Biopharma EPS misses by $0.03 [5/6/2021 5:25 PM] Vor Reports First Quarter 2021 Financial Results and Provides Company Update [May-06-21 04:08PM] How Many Vor Biopharma Inc. (NASDAQ:VOR) Shares Do Institutions Own? [May-07-21 10:30AM]